(S)-5,5-dimethyl-7-(1-phenylethyl)-2-(pyridin-3-ylamino)-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one

ID: ALA3884884

PubChem CID: 70942743

Max Phase: Preclinical

Molecular Formula: C21H21N5O

Molecular Weight: 359.43

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@@H](c1ccccc1)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21

Standard InChI:  InChI=1S/C21H21N5O/c1-14(15-8-5-4-6-9-15)26-18-17(21(2,3)19(26)27)13-23-20(25-18)24-16-10-7-11-22-12-16/h4-14H,1-3H3,(H,23,24,25)/t14-/m0/s1

Standard InChI Key:  LNCUDNJUDSTTIM-AWEZNQCLSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    1.1061   -9.8517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5188   -9.1459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7013   -9.1414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1271  -10.5144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8351  -10.9233    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5448  -10.5139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5420   -9.6912    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1282   -9.6948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8355   -9.2852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6644   -8.4859    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8514   -8.4016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2116   -7.8775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0117   -8.0484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4428   -7.6939    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2531  -10.9214    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9602  -10.5117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6652  -10.9196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3718  -10.5106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3710   -9.6925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6576   -9.2852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9540   -9.6965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9592   -7.1002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2613   -8.8283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0606   -8.9994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6096   -8.3916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3537   -7.6101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5550   -7.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  8  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  9  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  2  1  0
  2  8  1  0
 12 13  1  0
 10 12  1  0
 11 14  2  0
  6 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 12 22  1  1
 13 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 13  1  0
M  END

Associated Targets(Human)

MARK3 Tchem Serine/threonine-protein kinase c-TAK1 (2532 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MARK4 Tchem MAP/microtubule affinity-regulating kinase 4 (1536 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1746AlogP: 4.00#Rotatable Bonds: 4
Polar Surface Area: 71.01Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.43CX Basic pKa: 5.27CX LogP: 3.75CX LogD: 3.75
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: -1.02

References

1. Katz JD, Haidle A, Childers KK, Zabierek AA, Jewell JP, Hou Y, Altman MD, Szewczak A, Chen D, Harsch A, Hayashi M, Warren L, Hutton M, Nuthall H, Su HP, Munshi S, Stanton MG, Davies IW, Munoz B, Northrup A..  (2017)  Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors.,  27  (1): [PMID:27816515] [10.1016/j.bmcl.2016.08.068]

Source